Catalyst Wire Dossier Catalyst Wire Dossier

Belviq XR

lorcaserin hydrochloride extended-release (Belviq XR) · Eisai Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Belviq XR, covering 2021-07-19 to 2021-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years [Phase 4]

See pricing